Deborah reached a significant clinical milestone when it implanted its 200th WATCHMAN device, which closes the left atrial appendage. With this closure, patients with non-valvular atrial fibrillation have an alternative to long-term warfarin medication therapy (which thins the blood), since dangerous blood clots which could cause a stroke are prevented from entering the bloodstream. This milestone is a testament to the procedural excellence of the entire WATCHMAN team.
